for replacement teraphy – primary immunodeficiency syndromes; congenital agammaglobulinaemia or hypogammaglobulinaemia, severe combined immune deficiency, common variable immune deficiency, Wiskott-Aldrich syndrome; транзиторная гипогаммаглобулинемия у детей
secondary antibody deficiency syndrome — cytopenia of various nature (acute and chronic
leukosis, aplastic anemia, post-cytostatic therapy condition), severe forms of bacterial toxic and
viral infections (including surgical implications accompanied by bacteriemia and septicopyemic
conditions and while preparing surgical patients for operations);
autoimmune diseases — idiopathic thrombocytopenic purpura with a high hemorrhage risk or
before a surgical intervention to adjust the number of thrombocytes, Guillain-Barre syndrome,
chronic general neuropathy (demyelinating), general myopathy, Wegener's granulomatosis,
dermatomyositis, systemic connective tissue diseases (rheumathoid arthritis), Kawasaki syndrome;
bone marrow transplantations
publications:
Мальцев Д.В.:Внутривенная иммуноглобулинотерапия при рассеянном склерозе
Next
В/в иммуноглобулин в лечении гриппа и пневмонии (укр.)
Next
Мальцев Д.В.:Иммуноглобулинотерапия при аутоиммунных заболеваниях периферич.нервной...
Next
Стандартные в/в иммуноглобулины для лечения тяжелых форм гриппа
Next
Роль заместительной иммунной терапии в лечении первичных и профилактике вторичных...
Next
Ассоциация аутоимунных демиелизирующих бол.нервн.с-мы с гуморальными иммунодеф...
Next
Нормальные и специфические иммуноглобулины ...(гинекология)
Next
Каминский В.В: Ведение беременных при ассоциации ВИЧ и герпесвирусной инфекции
Next
You go to the specialized section, which is part of the Biopharma Website. The section is intended exclusively for healthcare professionals (hereinafter - certified medical professionals) and contains professional specialized information on prescription drugs: their name, composition, characteristics, methods of application, therapeutic properties, possible adverse effects, possible contraindications and other professional specialized information. The information on prescription drugs produced by Biopharma is intended solely for review and is not a guide for self-diagnosis or treatment. Do you confirm that you are a certified medical practitioner and is aware of the limitations on the availability of professionally specialized information on prescription drugs manufactured by Biopharma?